Learning Opportunities

Suggest a workshop or an idea for a workshop

Seek out knowledge.

Return with insight.

 

Here you will find information on workshop offerings, HQP travel awards and lab exchanges.

 

cihr-20160923-54

 

BioCanRx Events

 

Summit for Cancer Immunotherapy
June 25-28, 2017 | Gatineau-Ottawa
 
Each year, BioCanRx will fund up to 100 HQP to attend Summit4CI through a conference abstract competition. We will be accepting abstracts in early 2017 for Summit4CI 2017.
 
Summit4CI 2016 was a joint event between the Canadian Cancer Immunotherapy Consortium and BioCanRx. It took place June 26-29, 2016 in Halifax, Nova Scotia. The conference highlighted the most promising cancer biotherapeutics discoveries and clinical research in Canada and around the world. An exciting program of distinguished and up-and-coming researchers spoke about the sector, from its basic discoveries to its clinical, social and ethical implications, to its adoption by industry.
 
For more information, visit www.cancersummit.ca.

 
Summit4CI HQP Training Workshops Sunday, June 25, 2017 | Gatineau-Ottawa


Taking place before the Summit for Cancer Immunotherapy, BioCanRx will host training workshops for HQP that will focus on professional and career development.
 
At Summit4CI 2016, these pre-conference training sessions focused on providing a high-level overview of the trends and career opportunities within the Canadian biotechnology labour market. The first session was a look at the sector and was done in collaboration with BioTalent Canada. This session was complemented with a career panel that highlighted individuals with previous academic backgrounds in cancer research and now working in academia, business, law, industry, or the non-profit sector.
 
For more information about the workshop, please contact Jovian Tsang by email at jtsang@biocanrx.com or at 613-737-8149.

 

 

HQP Travel Awards and Lab Exchanges

 
img_2005
 
BioCanRx HQP Travel Awards and Lab Exchanges will enable HQP to access external opportunities not offered by the network. Please see the criteria below to determine the appropriate opportunity for you!
 
If you have any questions about these programs, please contact Jovian Tsang at jtsang@biocanrx.com, Manager of HQP Training Programs
 

HQP Travel Awards Lab Exchange Program
Purpose To enrich HQP development relevant to BioCanRx’s mission that are offered by external organisations
  1. To establish partnerships focused on training, in particular skills development and technology transfer, as well as strengthen connections between network members and/or industry partners
  2. To create subject matter experts to act as resources for the BioCanRx network
Duration Up to 7 days Up to 3 months
Maximum Funding Up to $1,000 CAD Up to $3,000 CAD
Applicant Eligibility
  • Must be a HQP working under a BioCanRx investigator, or at a BioCanRx Core Facility1
  • HQP’s project or work responsibilities directly contribute to BioCanRx’s mission
  • Must not have received a BioCanRx HQP Travel Award before2
Event /Exchange Eligibility
  • Must relate to one of BioCanRx’s priority areas:
    • synthetic antibody therapy
    • immune cell therapies
    • oncolytic viruses
    • clinical, social and economic implications of cancer biotherapeutics research
  • Partnering research group/industry partner must provide specialised skills training or technology transfer not widely available3
  • Knowledge/training gained will benefit all of the following:
    • HQP’s project/work responsibilities
    • HQP’s career development
    • Lab group/team
    • BioCanRx network
Eligible Expenses4
  • Travel
  • Accommodation
  • Meals
Reporting Post-event feedback form Post-exchange report
Application Deadline
  • June 9, 2017
  • August 18, 2017
  • November 17, 2017
  • February 16, 2018
Applications Apply Here Apply Here

 

1 Highly qualified personnel are defined as any staff member working for a principal investigator, which includes but is not limited to: graduate students, postdoctoral fellows, research associates, technical or clinical research staff.
2 Subject to daily maximums
3 Priority will be given to exchanges between BioCanRx research/clinical groups or between a BioCanRx research group and industry partner
4 This criteria excludes those who have received HQP Travel Awards to the Summit for Cancer Immunotherapy

 

 

Past BioCanRx HQP Travel Awardees

 
Dr. Christopher Helsen, PhD; Bramson Lab, McMaster University

 
Attended the Immunotherapy: The Ontario Landscape meeting
 
“Receiving the Travel award was an immense honor. For me the main focus of the award lay in the competition. Preparing the required documents and research proposals as well as future research plans was a very good learning experience. As a young researcher trying to transition into a faculty position these kinds of competitions are very important. In this regard, the award competitions are exactly what are needed. This makes the competition in itself worth it, irrespective of the success in obtaining the award.”
 

Dr. Lee-Hwa Tai, PhD; Auer Lab, Ottawa Hospital Research Institute

 
Attended the Immunotherapy: The Ontario Landscape meeting
 
“As a senior PDF transitioning to young PI status, listening to the talks about cancer immunotherapy across Ontario both validated and challenged my own research ideas and projects. In addition, I got to socialize with my peers, get career management advice from mentors and network with potential collaborators.”

 

Angela Ahn, PHD Candidate; Ursini-Siegel Lab, Lady David Institute

 
Attended the Clinical Application of Tumour-infiltrating Lymphocyte Therapy workshop
 
“It was an absolute privilege being supported by BioCanRx Travel Award to cover the cost of attending this conference. The application and reimbursement procedure and communication from the coordinators Jovian and Rebecca were exceptionally clear and prompt.”

 

Anne Monette, PHD; Lapointe Lab, Université de Montréal

 
Attended the Clinical Application of Tumour-infiltrating Lymphocyte Therapy workshop
 
“My experience attending the Clinical Application of Tumour-infiltrating Lymphocyte Therapy (CATT) Workshop was very memorable. It was a great opportunity to attend this meeting with the Canadian leaders in adoptive cell therapy, to understand the recent advances of TIL-therapy and ongoing and upcoming challenges related to both the clinical protocols, policy and regulatory affairs, costs associated to treatment, and also to learn from international specialists on the status of these subjects in their regions. Overall, I learned many important things there that will most certainly be enriching to my personal career development in this very exciting field of research. I am grateful for having been awarded the BioCanRx travel award, and also for having been given a chance to present some of my own research findings to such an impressive group of experts in the field of onco-immunology.”

 

Victoria Hodgson, Research Assistant II; Nelson/Webb Lab, BC Cancer Agency

 
Attended the Clinical Application of Tumour-infiltrating Lymphocyte Therapy workshop
 
“Receiving the BioCanRx Travel Award enabled me to attend the TIL therapy workshop in Toronto to benefit both my own professional development and our newly emerging TIL therapy program in Victoria BC. The Travel Award coverage for my flights, accommodation, and meals was plenty for my experience at this workshop.

My professional development has benefited through networking and connections made at the workshop. I value having the opportunity to discuss the specifics of TIL therapy with other professionals, and to contribute my own expertise and ideas to this field. Contributing as a trainee modulator and as an author on the workshop summary will also positively impact my professional development. Through this experience my perspective of TIL therapy in Canada and worldwide has been broadened, positively impacting my future work in this field.”

 

Scott Walsh, PHD; Wan Lab McMaster University

 
Attended the Clinical Application of Tumour-infiltrating Lymphocyte Therapy workshop
 
“The CATT workshop was a unique educational and networking experience. The smaller size of the workshop allowed for an intimate atmosphere which in turn fostered insightful discussions among world experts in the field of clinical TIL therapy. By attending I was able to establish networking connections with these experts and elaborate on the research activities of my lab, which will help foster future collaborations. As a young Canadian researcher in the field of ACT therapy it was inspiring to see that Canada has a strong TIL therapy program that is on par with similar programs in the US and Europe.”